70 likes | 87 Vues
According to Fact.MR, the parenteral drugs market is poised to reach a staggering valuation of US $ 802Bn by the end of the forecast period (2019-2029).<br>
E N D
Copyright © Fact.MR All Rights Reserved According to Fact.MR, the parenteral drugs market is poised to reach a staggering valuation of US $ 802Bn by the end of the forecast period (2019-2029).
About Fact.MR Fact.MR (FMR) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMR is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Social Media Research Customized Research Syndicated Research Investment Research Research Capabilities Sector Coverage • Automotive and Transportation • Electronics, Semiconductor, and ICT • Retail and Consumer Products • Industrial Automation and Equipment • Customized Research • Syndicated Research • Investment Research • Social Media Research • Chemicals & Materials • Food and Beverages • Services and Utilities • Energy, Mining, Oil, and Gas For detailed subscription information please contact Website: www.factmr.com For sales queries or new topics email us on: sales@factmr.com Subscription Information Copyright © Fact.MR All Rights Reserved
ResearchMethodology Research & Intelligence Data Collection Actionable Insights Data Filter & Analysis Business Solution 1 Market profiling 2 Formulating discussion guide • Identifying key opinion leaders • Questionnaire design • In-depth interviews • Coverage across value chain 3 A Developing list of respondents • Key industry experts • Channel study • Developments • Market dynamics • Products • Conclusions Primary Research 4 SOLUTION Data collection • Market participants • Key strengths • Product portfolio • Mapping as per value chain • Key focus segments B 5 Desk Research Data validation 6 C Data analysis Primary Research # • Secondary Research # • Paid Publications# Company Analysis • Linkedin • Zoominfo • Salesforce • Avention • Company websites • Company annual reports • White papers • Financial reports • Factiva • GBI • Genios • Meltwater 7 Insights Systematic Research Approach Copyright © Fact.MR All Rights Reserved
Report Scope & Segmentation Self-administered drugs through pre-filled syringes offer opportunities to reduce consumer spending on caregiver fees. Furthermore, manufacturers are gaining sharper profit margins with the introduction of this drug delivery medium in their portfolio. On this backdrop, the global parenteral drugs market estimated at US$ 451 Bn in 2019, is projected to witness moderate growth during the forecast period (2019 – 2029). Report Scope Digital Remittance Copyright © Fact.MR All Rights Reserved
Key Takeaways • By product type, monoclonal antibodies segment accounts for maximum market share in terms of revenue in the parenteral drugs market. This is primarily attributed to the rising adoption of biologics and subsequent rise in the number of biologics approved for marketing. • North America and Europe collectively hold over 60% of the parenteral drugs market share owing to the rise in new product launches in the regions. • Hospital pharmacies segment is expected to be the dominant distribution channel in the parenteral drugs market. • The parenteral drugs market is highly fragmented. Some of the prominent parenteral drug manufacturers include Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, and Pfizer Inc., among many others. • “Patent expiration of branded products and fewer new product launches have resulted in the rise of generic versions of drugs, and in the emergence of a number of players in the market – this factor has intensified total parenteral drugs sales,” says a Fact.MR analyst. • Get To Know More About The Market Copyright © Fact.MR All Rights Reserved
Competitive Landscape • Merck & Co. Inc., • Teva Pharmaceutical Industries Ltd., • Sanofi S.A., • Novartis AG, Request For Sample Report Copyright © Fact.MR All Rights Reserved
“Setting goals is the first step in turning the invisible into the visible” Website: www.factmr.com For sales queries or new topics email us on: sales@factmr.com For other queries contact:Suite 9884, 27 Upper Pembroke Street,Dublin 2, Ireland Tel: +353-1-6111-593 Copyright © Fact.MR All Rights Reserved